|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 9/0056 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 9/1652 | (2013.01) | ||
| A61K 9/5047 | (2013.01) | ||
| A61K 9/50 | (2006.01) | ||
| A61K 31/401 | (2013.01) | ||
| A61K 31/198 | (2006.01) | ||
| A61K 31/401 | (2006.01) | ||
| A61K 31/405 | (2013.01) | ||
| A61K 31/405 | (2006.01) | ||
| A61K 31/4172 | (2013.01) | ||
| A61K 31/4172 | (2006.01) | ||
| A23L 33/175 | (2016.08) | ||
| A23L 33/175 | (2016.01) | ||
| A61K 33/00 | (2013.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61K 9/1635 | (2013.01) | ||
| A21D 2/24 | (2006.01) | ||
| A61K 9/205 | (2013.01) | ||
| A23L 33/16 | (2016.01) | ||
| A61K 9/5073 | (2013.01) | ||
| A61P 3/00 | (2006.01) | ||
| A23L 33/15 | (2016.08) | ||
| A23L 33/15 | (2016.01) | ||
| A23L 33/16 | (2016.08) | ||
| A61K 33/00 | (2006.01) | ||
| A21D 2/245 | (2013.01) | ||
| A61K 9/16 | (2006.01) | ||
| A61K 31/198 | (2013.01) | ||
| A61P 3/00 | (2018.01) | ||
| A61K 31/00 | (2013.01) |
| (11) | Patento numeris | 4129270 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 22178328.5 |
| Europos patento paraiškos padavimo data | 2016-09-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2023-02-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-09-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201562233695 P | 2015-09-28 | US |
| (72) |
REINER, Alberto , IT
REINER, Giorgio , IT
|
| (73) |
APR APPLIED PHARMA RESEARCH S.A. ,
Via Corti 5, 6828 Balerna,
CH
|
| (54) | MODIFIED RELEASE ORALLY ADMINISTERED AMINO ACID FORMULATIONS |
| MODIFIED RELEASE ORALLY ADMINISTERED AMINO ACID FORMULATIONS |